No worries @Rick
I think the market is reacting to the cashflow in the half. The lack of analyst coverage is reflected in the share registry and thus you have a lot of 'retail investors' who drive the share price. Whenever I tried to point out to HC posters that the December cash balance would be significantly less than the June cash balance, I generally got accused of being a downramper and/or not knowing what I'm talking about (that last one is probably fair tbh). That probably gives you an idea of the level of shareholder sophistication. The cash balance was even lower than I expected to be honest but is explained by the investment in inventory. It would be good to know how much of that inventory relates to the $35m in orders they plan to deliver in FY23/24. I'm sure some is but they haven't explained it as such. Instead they've said it's to mitigate supply chain disruption and enable rapid delivery. Overall I take the inventory build as bullish.
Now the Ukraine order is out of the way I'm expecting a few of things to happen. One is cashflow should now normalise and I'd expect positive flows in 2H. Second is revenue has probably hit a high water mark for a half year for the time being. Their strategy is targeting big military deals and that's great (if it works out) as it will allow for repeats of the growth we've seen in the past 12 months, but is likely to be lumpy. The third is margins are likely to contract. You've got a combination of exceptional margins from the Ukraine deal (now finished) plus the biggest contribution to the 2H result - i.e. drone sales - being a relatively low margin product. But I take the view that as long as you know to expect those things you can profit from them.
Probably the thing that most interested me in the most in the result was the disclosure they're progressing plans to build an XTclave in the "US and other regions in FY24". I don't know exactly how to feel about that. On the one hand the new management said they wouldn't do that unless there was a specific driver for it - the most cited being awarded the US army's next generation combat helmet contract - and so doing so without that is a break in trust. On the other hand you can take the view that they're signalling a deal like that is imminent. Under the previous management I wouldn't trust that the latter was the case and although I have a better opinion of current management, I'm still nervous as they're not cheap to build. If they did win that contract it would be an absolute game changer.
Just on the analyst coverage there's a couple of analyst research notes on the XTEK website. One is Bell Potter and is predictably bullish given they no doubt will be sniffing around for corporate work, and the other is MST Access.
Interesting timing @Minku1973 as I've been working on a write up on them in the last week. The complication with XTEK is the massive and possibly game changing order they received early this year, which was only part completed at year end (it's widely assumed the order was for Ukraine but that hasn't been confirmed). Given the urgency for the order to be delivered, it was made on very favourable terms. This included price and led to a gross margin jump from 27% in 1H to 52% in 2H. It also included payment terms as they received the full amount of the order up front. That up front payment explains the jump in free cash flow but expect that to unwind in FY23 as they pay for the remainder of the order to be completed (my guess is they'll be cash flow negative in FY23 and almost certainly in 1H). There was some horrendous accounting treatment of the unfulfilled portion of that payment in the Annual Report, which was shown as Trade Payables instead of Unearned Income and not even explained in the Notes. I spoke to the CFO about this and the explanation for that was...unsatisfactory.
As you said the company believes it can beat FY22 revenue this year. My view is if they don't, they may as well give up. Fulfilling the remainder of that one order, which they have now done, means they've already booked more than half the total revenue of last year without doing anything else in either their Ballistics division or Technology division. I would be hoping to see something like $45 million in 1H and $25 million in 2H, but it will be a lumpy business so we'll see.
Normally I'd step back from a company like this, realise they've been a serial disappointer for decades and write them off as a business who have received a one-off windfall (possibly on the back of misery of others). But in this case I suspect there is more going on here. They're under completely new management who are showing the early signs of streamlining the business and are well positioned to benefit from a broad tailwind, both in terms of specific global tensions and a broad thematic of governments generally growing the size of their armed forces. What it makes XTEK worth is the really tough question I'm struggling to answer though. Anyway I'll try to finish the write up in the next couple of days.
You may have already seen it but they appeared on Coffee Microcaps a couple of weeks ago, which you can access here - starts at about 1:02:30.
[Bought small parcel of them here yesterday and in RL (at better prices) a couple of weeks ago]